Benjamin Cravatt insider trades
Open-market stock purchases and sales by Benjamin Cravatt, Director at Alnylam Pharmaceuticals, Inc, from SEC Form 4 filings since Aug 5, 2020.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jun 1, 2026 | ALNY Alnylam Pharmaceuticals, Inc | Bought (not open market) | — |